Our company is known in the medical industry as a promising enterprise, engaged in offering a superior quality Caffeine Citrate Injection USP 20 mg. These injections are used for the short-term treatment of a breathing problem (apnea) in premature infants. Our quality controllers perform a series of test against various parameters. Owing to their effectiveness & quick action, these injections are highly demanded in the market. Caffeine Citrate Injection USP 20 mg basically blocks certain proteins (adenosine receptors) which lead to improved breathing in these infants.
Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
"We are inviting inquiries only from South America, Africa, Middle East, Cih, South East Asia."
Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD.
1302, Rupa Solitaire, Millenium Business Park (MBP), Next to Hotel Ramada, Mahape, Navi Mumbai - 400710, Maharashtra, India